Members |
targetComponentId |
tolterodintartrat 2 mg, kapsel med modifierad frisättning |
Product containing only tolterodine in oral dose form (medicinal product form) |
tolterodin L-tartrat 2 mg, depåkapsel |
Product containing only tolterodine in oral dose form (medicinal product form) |
Tolterodine tartrate 4mg m/r capsule |
Product containing only tolterodine in oral dose form (medicinal product form) |
toluendiisocyanatspecifikt extrakt |
Toluene-2-4-diisocyanate |
tomat, livsmedel |
Tomato (substance) |
Tomilol |
Timolol (substance) |
Tonsil (& peritonsillar region) |
Palatine tonsillar structure |
Tooth attrition |
Excessive attrition of teeth |
Tooth decalcification |
Incipient enamel caries |
allergi mot lokala kombinationspreparat med dexametason |
Allergy to dexamethasone |
allergi mot lokalt kombinationspreparat med hydrokortison |
Allergy to hydrocortisone (finding) |
lokal kortikosteroid, grupp 1 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 2 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 3 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 4 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 5 |
Glucocorticoid (substance) |
lokal kortikosteroid, grupp 6 |
Glucocorticoid (substance) |
allergi mot lokal dexametason |
Allergy to dexamethasone |
allergi mot lokalt estradiol |
Allergy to estradiol (finding) |
allergi mot lokal hydrokortison |
Allergy to hydrocortisone (finding) |
allergi mot prednisolonpreparat för lokal behandling |
Allergy to prednisolone |
allergi mot lokal salicylsyra |
Allergy to salicylic acid (finding) |
selen för lokalt bruk |
Selenium |
svavel för lokal behandling |
Sulfur |
Topotecan 1mg powder for infusion solution vial |
Topotecan (as topotecan hydrochloride) 1 mg powder for solution for injection vial |
Torday's elephant shrew |
Family Macroscelididae |
Toreks orkiopexioperation |
Orchidopexy |
torasemid 10 mg/ml, injektionsvätska, lösning, ampull |
Product containing only torasemide in parenteral dose form (medicinal product form) |
Torulopsis |
Candida |
Torulopsis candida |
Candida saitoana |
Torulopsis glabrata |
Candida glabrata (organism) |
Torulopsis pintolopesii |
Candida pintolopesii |
uppskattat dagligt totalt energiintag |
Estimated quantity of intake of energy in 24 hours (observable entity) |
Tourette's disorder |
Gilles de la Tourette's syndrome |
graviditetstoxikos |
Pre-eclampsia (disorder) |
Toxic effect |
Poisoning |
Toxic effect from eating shellfish |
Toxic effect from eating shellfish (disorder) |
Toxic effect from noxious substance eaten as food, NEC |
Toxic effect of noxious substance eaten as food |
Toxic effect of chiefly nonmedicinal substance, NEC |
Toxic effect of chiefly nonmedicinal substance |
Toxic effect of hydrocarbon gas, NEC |
Toxic effect of hydrocarbon gas |
toxisk effekt av nitroderivat och aminoderivat av bensen och bensenhomologer |
Poisoning caused by substance with benzene structure (disorder) |
Toxic effect of non-petroleum-based solvent |
Toxic effect of nonpetroleum-based solvent |
Toxic effect of other alcohol, NEC |
Toxic effect of alcohol |
Toxic effect of other nonpetroleum-based solvent, NEC |
Toxic effect of nonpetroleum-based solvent |
Toxic encephalopathy |
Toxic encephalopathy |
Toxic porphyria, NEC |
Porphyria due to toxic effect of substance |
leksak eller skämtartikel |
Toy |
toxisk effekt av leksak eller skämtartikel |
Toy causing toxic effect |
plats för trakeostomi |
Tracheostomy stoma |
trakeostomi, akut åtgärd genom åtkomst via membrana cricothyreoidea |
Emergency cricothyroidotomy |
tramadolhydroklorid 300 mg, kapsel med modifierad frisättning |
Product containing only tramadol in oral dose form (medicinal product form) |
tramadolhydroklorid 300 mg, depåkapsel |
Product containing only tramadol in oral dose form (medicinal product form) |
tramadolhydroklorid 50 mg, löslig tablett |
Product containing precisely tramadol hydrochloride 1 milligram/1 milliliter conventional release oral solution (clinical drug) |
Tramazoline hydrochloride+dexamethasone isonicotinate |
Product containing dexamethasone and tramazoline (medicinal product) |
trandolaprilallergi |
Non-allergic hypersensitivity to trandolapril (finding) |
Trandolapril+verapamil hydrochloride |
Product containing trandolapril and verapamil (medicinal product) |
trandolapril 1 mg + verapamilhydroklorid 240 mg, tablett med modifierad frisättning |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
trandolapril 1 mg + verapamilhydroklorid 240 mg, depåtablett |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
trandolapril 2 mg + verapamilhydroklorid 180 mg, tablett med modifierad frisättning |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
trandolapril 2 mg + verapamilhydroklorid 180 mg, depåtablett |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
trandolapril 2 mg + verapamilhydroklorid 240 mg, tablett med modifierad frisättning |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
trandolapril 2 mg + verapamilhydroklorid 240 mg, depåtablett |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
trandolapril 4 mg + verapamilhydroklorid 240 mg, tablett med modifierad frisättning |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
trandolapril 4 mg + verapamilhydroklorid 240 mg, depåtablett |
Product containing only trandolapril and verapamil in oral dose form (medicinal product form) |
tranexamsyra 100 mg/ml, injektionsvätska, lösning, flaska 10 ml |
Tranexamic acid 100 mg/mL solution for injection |
Tranexamic acid 100mg/mL injection |
Tranexamic acid 100 mg/mL solution for injection |
tranexamsyra 100 mg/ml, intravenös vätska, lösning, flaska 10 ml |
Tranexamic acid 100 mg/mL solution for injection |
Transacylase |
Transacylase |
Transcarbamoylase |
Transcarbamoylase |
Transcarboxylase |
Transcarboxylase |
Transcortin |
Corticotropin binding globulin |
allergi mot transdermalt nitroglycerin |
Allergy to nitroglycerin |
Transfer of forearm tendon or muscle |
Transposition procedure |
Transformiminase |
Transformiminase |
Transformylase |
Transhydroxymethylase |
Transhepatic |
Transhepatic approach |
Transhydroxymethylase |
Transhydroxymethylase |
Transient |
Transitory |
Transient hematological disorder, NEC |
Transient neonatal hematological disorder |
klinisk handläggningsplan för transitorisk ischemisk attack |
Transient ischemic attack clinical management plan (record artifact) |
Transient situational disturbance |
Adjustment disorder |
Transorbital |
Transorbital approach |
Transplant of lymphatic structure |
Transplantation of lymphatic structure |
transsexualism |
Transsexual (finding) |
Transsexualism NOS |
Transsexual (finding) |
transsexualism, tidigare asexuell |
Previously asexual transsexual (finding) |
transsexualism, tidigare heterosexuell |
Previously heterosexual transsexual (finding) |
transsexualism, tidigare homosexuell |
Previously homosexual transsexual (finding) |
transsexualitet med asexuell anamnes |
Previously asexual transsexual (finding) |
transsexualitet med heterosexuell anamnes |
Previously heterosexual transsexual (finding) |
transsexualitet med homosexuell anamnes |
Previously homosexual transsexual (finding) |
Transsexuality with unspecified sexual history |
Transsexual (finding) |
transtorakal ekokardiografi |
Transthoracic echocardiography (procedure) |
transuretral prostatektomi genom stansning med Youngs punch |
Transurethral prostatectomy |
Transverse presentation |
Transverse lie |
transvetism |
Cross-dressing |
Trastuzumab |
Trastuzumab (substance) |
Traumatic perforation |
Perforating wound |
traumatiska hudförändringar |
Injury to skin caused by trauma |
genomförd resevaccination |
Travel vaccination given (situation) |
Treatment of glaucoma |
Medicinal product acting as antiglaucoma agent (product) |